| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c23d84d2f6dd5c06aea424c9fb3bc340
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b4148f919383ed44f494bfb7e512618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba8eddb84b6124e133110a7cfd98de2c |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-01 |
| filingDate |
2019-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e030c74100bf524b55b3632755a4732c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbd84b4cd1f3e5471549817a6130ead8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3c27775ad0393449e2477301955e0cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ff28a421e421120ac742af79ec87405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d3d3fcf82fae07d892ac9828850d85d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa75390f787124372259c17fd6c9e7c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edc6b0f513133ba8bd1f1cb7cac2f8c4 |
| publicationDate |
2019-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109880839-A |
| titleOfInvention |
Preparation method of double genetic engineering vaccine of Mycoplasma suis pneumonia and porcine circovirus |
| abstract |
The invention relates to the technical field of vaccines, in particular to a preparation method and application of a baculovirus-expressed Mycoplasma suis pneumonia and porcine circovirus type 2 duplex genetic engineering vaccine. A dual genetic engineering vaccine of Mycoplasma suis pneumonia and porcine circovirus type 2, characterized in that the recombinant baculovirus vaccine comprises a recombinant protein encoded by a gene as shown in SEQ ID NO.1 and a recombinant protein as shown in SEQ ID NO.2 The recombinant protein encoded by the gene is shown. The above-mentioned dual genetic engineering vaccine can produce effective immune protection after immunizing animals, and has a good application prospect for the prevention and control of Mycoplasma suis pneumonia and porcine circovirus type 2 diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113913465-A |
| priorityDate |
2019-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |